Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Iron-mediated oxidative stress is implicated in the pathogenesis of renal ischemia-reperfusion injury. Hepcidin is an endogenous acute phase hepatic hormone that prevents iron export from cells by inducing degradation of the only known iron export protein, ferroportin. In this study, we used a mouse model to investigate the effect of renal ischemia-reperfusion injury on systemic iron homeostasis and determine if dynamic modulation of iron homeostasis with hepcidin has therapeutic benefit in the treatment of AKI. Renal ischemia-reperfusion injury induced hepatosplenic iron export through increased ferroportin expression, which resulted in hepatosplenic iron depletion and an increase in serum and kidney nonheme iron levels. Exogenous hepcidin treatment prevented renal ischemia-reperfusion-induced changes in iron homeostasis. Hepcidin also decreased kidney ferroportin expression and increased the expression of cytoprotective H-ferritin. Hepcidin-induced restoration of iron homeostasis was accompanied by a significant reduction in ischemia-reperfusion-induced tubular injury, apoptosis, renal oxidative stress, and inflammatory cell infiltration. Hepcidin -: deficient mice demonstrated increased susceptibility to ischemia-reperfusion injury compared with wild-type mice. Reconstituting hepcidin-deficient mice with exogenous hepcidin induced hepatic iron sequestration, attenuated the reduction in renal H-ferritin and reduced renal oxidative stress, apoptosis, inflammation, and tubula…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, a recent study showed that exogenous hepcidin is protective against renal ischaemia–reperfusion injury and oxidative stress, and that hepcidin deficiency exacerbates these forms of injury32.”
From Iron homeostasis in host defence and inflammation (2015) · cites this paper as [32]
Citations
Cites
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Dysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Reactive species mechanisms of cellular hypoxia-reoxygenation injury
Li, C., & Jackson, R. M. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00112.2001 · Cited by 1,043
Interleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983
Apoptosis and acute kidney injury
Havasi, A., & Borkan, S. C. (2011) · Kidney International · doi:10.1038/ki.2011.120 · Cited by 653
Amelioration of Ischemic Acute Renal Injury by Neutrophil Gelatinase-Associated Lipocalin
Mishra, J., Mori, K., Ma, Q., Kelly, C., Yang, J., Mitsnefes, M., Barasch, J., & Devarajan, P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000145013.44578.45 · Cited by 536
Cited by
Ferroptosis: Mechanisms and links with diseases
Yan, H.-F., Zou, T., Tuo, Q.-Z., Xu, S., Li, H., Belaidi, A. A., & Lei, P. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00428-9 · Cited by 1,471
Iron homeostasis in host defence and inflammation
Ganz, T., & Nemeth, E. (2015) · Nature Reviews Immunology · doi:10.1038/nri3863 · Cited by 843
Overview of iron metabolism in health and disease
Dev, S., & Babitt, J. L. (2017) · Hemodialysis International · doi:10.1111/hdi.12542 · Cited by 462
Regulated cell death pathways in kidney disease
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., & Ortiz, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00694-0 · Cited by 393
Macrophages in Renal Injury and Repair
Huen, S. C., & Cantley, L. G. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034219 · Cited by 377
Bayır, H., Dixon, S. J., Tyurina, Y. Y., Kellum, J. A., & Kagan, V. E. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00689-x · Cited by 331
The multifaceted role of iron in renal health and disease
van Swelm, R. P. L., Wetzels, J. F. M., & Swinkels, D. W. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0197-5 · Cited by 275
The pathological role of ferroptosis in ischemia/reperfusion-related injury
Yan, H.-F., D. O. N. A. S. K. L. O. B., Tuo, Q.-Z., Yin, Q.-Z., Lei, P., & C. U. O. T. C. M. (2020) · Zoological Research · doi:10.24272/j.issn.2095-8137.2020.042 · Cited by 248
“Indeed, Iron chelation has been reported to be beneficial in some animal models of IRI (Galaris et al., 2006; Scindia et al., 2015).”
Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss
Maremonti, F., Meyer, C., & Linkermann, A. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021101293 · Cited by 197
Mechanisms of haemolysis-induced kidney injury
Van Avondt, K., Nur, E., & Zeerleder, S. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0181-0 · Cited by 204
Heme Oxygenase 1 as a Therapeutic Target in Acute Kidney Injury
Bolisetty, S., Zarjou, A., & Agarwal, A. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.10.037 · Cited by 149
Iron overload: Effects on cellular biochemistry
Sousa, L., Oliveira, M. M., Pessôa, M. T. C., & Barbosa, L. A. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.029 · Cited by 138
Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury
Pan, Y., Wang, X., Liu, X., Shen, L., Chen, Q., & Shu, Q. (2022) · Antioxidants · doi:10.3390/antiox11112196 · Cited by 142
Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1
Deng, Y., Zeng, L., Liu, H., Zuo, A., Zhou, J., Yang, Y., You, Y., Zhou, X., Peng, B., Lu, H. R., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103360 · Cited by 126
“Meanwhile, ischemia-reperfusion injury is often accompanied by iron homeostasis imbalance [40], excessive free iron accelerates ROS production and lipid peroxidation via Fenton reaction, which exacerbate ferroptosis.”
BackgroundThe in vivo evidence for regulated necrosis
Tonnus, W., & Linkermann, A. (2017) · Immunological Reviews · doi:10.1111/imr.12551 · Cited by 111
The Cross‐Link between Ferroptosis and Kidney Diseases
Wang, J., Liu, Y., Wang, Y., & Sun, L. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6654887 · Cited by 115
“The regulation of iron by FPN is also dominated by hepcidin, which is a protective factor for AKI, and its antikidney injury is related to iron homeostasis restoration and inflammation inhibition [66, 67].”
BackgroundIron homeostasis and disorders revisited in the sepsis
Liu, Q., Wu, J., Zhang, X., Wu, X., Zhao, Y., & Ren, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.025 · Cited by 116
Iron Homeostasis in Healthy Kidney and its Role in Acute Kidney Injury
Scindia, Y. M., Leeds, J. T., & Swaminathan, S. (2018) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2018.10.006 · Cited by 127
Self-citationAcute kidney injury and distant organ dysfunction–network system analysis
Matsuura, R., Doi, K., & Rabb, H. (2023) · Kidney International · doi:10.1016/j.kint.2023.03.025 · Cited by 108
Iron transport in the kidney: implications for physiology and cadmium nephrotoxicity
Thévenod, F., & Wolff, N. A. (2016) · Metallomics · doi:10.1039/c5mt00215j · Cited by 111
Zhang, X., & Li, X. (2022) · Metabolites · doi:10.3390/metabo12010058 · Cited by 90
“The expression of ferroportin is increased in response to export hepatosplenic iron, which results in the alterations of systemic iron homeostasis, including hepatosplenic iron depletion, and increased serum and kidney nonheme iron levels in the renal IRI animal model [58].”
BackgroundFerroptosis: From regulation of lipid peroxidation to the treatment of diseases
Lv, Y., Wu, M., Wang, Z., & Wang, J. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09778-2 · Cited by 89
“reported that renal IRI is closely related to iron metabolism (Scindia et al. 2015).”
BackgroundLong-term remote organ consequences following acute kidney injury
Shiao, C., Wu, P., Huang, T., Lai, T., Yang, W., Wu, C., Lai, C., Wu, V., Chu, T., & Wu, K. (2015) · Critical Care · doi:10.1186/s13054-015-1149-5 · Cited by 89
“Animal studies disclosed that injured kidneys may cause obviously higher inflammatory chemokines expression and renal fibrosis [34] as well as profound iron-mediated oxidative stress by disturbing systemic iron homeostasis [35], while supplement with hepcidin may increase the expression of renal H-ferritine and exhibi…”
BackgroundYu, Y., Li, C., Zhu, S., Jin, L., Hu, Y. W., Ling, X., Miao, C., & Guo, K. (2023) · European journal of medical research · doi:10.1186/s40001-023-00990-2 · Cited by 98
“Hepcidin-induced restoration of iron homeostasis was accompanied by significant reductions in ischaemia‒reperfusion-induced tubular injury, apoptosis, renal oxidative stress, and inflammatory cell infiltration [98].”
BackgroundIron, Hepcidin, and Death in Human AKI
Leaf, D. E., Rajapurkar, M. M., Lele, S. S., Mukhopadhyay, B. N., Boerger, E. A. S., Causland, F. R. M., Eisenga, M. F., Singh, K., Babitt, J. L., Kellum, J. A., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2018100979 · Cited by 69
“49 Chronic liver disease 94 (12) 37 (10) 57 (14) 0.”
Targeting Iron Homeostasis in Acute Kidney Injury
Walker, V. J., & Agarwal, A. (2016) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2016.01.003 · Cited by 66
Targeting ferroptosis in ischemia/reperfusion renal injury
Thapa, K., Singh, T. G., & Kaur, A. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02277-5 · Cited by 68
“Due to low glutathione levels, human fibroblasts cannot be cultured in cystine-free media (Conrad and Sato 2012; Scindia et al. 2015).”
BackgroundModulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis
Scindia, Y. M., Wlazlo, E., Ghias, E., Cechova, S., Loi, V., Leeds, J. T., Ledesma, J., Helen, C., & Swaminathan, S. (2020) · Kidney International · doi:10.1016/j.kint.2020.01.025 · Cited by 61
Self-citationvan Swelm, R. P. L., Wetzels, J. F. M., Verweij, V., Laarakkers, C. M., Pertijs, J. C. L. M., van der Wijst, J., Thévenod, F., Masereeuw, R., & Swinkels, D. W. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040461 · Cited by 64
Iron and Cadmium Entry Into Renal Mitochondria: Physiological and Toxicological Implications
Thévenod, F., Lee, W., & Garrick, M. D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00848 · Cited by 63
Iron Homeostasis Pathways as Therapeutic Targets in Acute Kidney Injury
Swaminathan, S. (2018) · The Nephron journals/Nephron journals · doi:10.1159/000490808 · Cited by 60
Self-citationCardiac Surgery–Associated Acute Kidney Injury
Scurt, F. G., Bose, K., Mertens, P. R., Chatzikyrkou, C., & Herzog, C. (2024) · Kidney360 · doi:10.34067/kid.0000000000000466 · Cited by 133
“229 While animal studies suggest its bene fi t, clinical trials are limited.”
BackgroundGuo, W.-Z., Fang, H., Cao, S., Chen, S., Li, J., Shi, J.-H., Tang, H.-W., Zhang, Y., Wen, P.-H., Zhang, J.-K., et al. (2019) · Hepatology · doi:10.1002/hep.30882 · Cited by 49
“Expression plasmids encoding truncated Steap3 (1-258, 259-488) or TAK1 (1-300, 1-390, 301-579, and 391-579) were amplified using PCR and cloned into pcDNA5-flag and pcDNA5-HA, respectively, using standard molecular”
Tarifeño-Saldivia, E., Aguilar, A., Contreras, D., Mercado, L. A., Lange, B. M., Márquez, K., Henríquez, A., Riquelme-Vidal, C., & Boltaña, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01296 · Cited by 59
Gong, Y., Wang, Y., Qu, Q., Hou, Z., Guo, T., Xu, Y., Qing, R., Deng, J., Wang, B., & Hao, S. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.029 · Cited by 58
Protective Role of Hepcidin in Polymicrobial Sepsis and Acute Kidney Injury
Scindia, Y. M., Wlazlo, E., Leeds, J. T., Loi, V., Ledesma, J., Cechova, S., Ghias, E., & Swaminathan, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00615 · Cited by 56
Self-citationWang, X., Zheng, X., Zhang, J., Zhao, S., Wang, Z., Wang, F., Shang, W., Barasch, J. M., & Qiu, A. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00072.2018 · Cited by 50
“In fact, hepcidin treatment alleviated ischemic AKI probably by limiting the efflux of hepatic or splenic iron and by decreasing serum iron (29).”
BackgroundIron Chelation as a Potential Therapeutic Strategy for AKI Prevention
Sharma, S., & Leaf, D. E. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060595 · Cited by 60
McCullough, K., & Bolisetty, S. (2020) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2020.01.007 · Cited by 46
Iron Metabolism: An Under Investigated Driver of Renal Pathology in Lupus Nephritis
Wlazlo, E., Mehrad, B., Morel, L. M., & Scindia, Y. M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.643686 · Cited by 47
“We have shown that hepcidin can mitigate systemic inflammation in settings of renal ischemia reperfusion injury (88), endotoxemia, polymicrobial sepsis (89), and SLE (90).”
BackgroundSelf-citationIron, ferroptosis, and new insights for prevention in acute kidney injury
Borawski, B., & Małyszko, J. (2020) · Advances in Medical Sciences · doi:10.1016/j.advms.2020.06.004 · Cited by 61
Choi, N., Whitlock, R. H., Klassen, J., Zappitelli, M., Arora, R. C., Rigatto, C., & Ho, J. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.06.091 · Cited by 51
Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents
Charlton, J., Pearl, V. M., Denotti, A. R., Lee, J. B., Swaminathan, S., Scindia, Y., Charlton, N., Baldelomar, E., Beeman, S., & Bennett, K. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.03.007 · Cited by 42
“Non-heme iron (μg/g) was calculated.(31)”
Self-citationThe Macrophage Iron Signature in Health and Disease
Mertens, C., Marques, O., Horvat, N. K., Simonetti, M., Muckenthaler, M. U., & Jung, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168457 · Cited by 47
Refaat, B., Abdelghany, A. H., Basalamah, M. A., El‐Boshy, M., Ahmad, J., & Idris, S. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418782696 · Cited by 42
Gadolinium toxicity: Iron and ferroportin as central targets.
Swaminathan, S. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.08.016 · Cited by 41
“Our recent studies in a model of ischemic kidney injury have also demonstrated pro-healing effects of macrophage iron retention [31].”
Self-citationThe role of ferroptosis in the development of acute and chronic kidney diseases
Zhou, Y., Zhang, J., Guan, Q., Tao, X., Wang, J., & Li, W. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30901 · Cited by 44
“Hepcidin prevented and attenuated iron overload and inflammatory response in renal of IR‐induced AKI (Scindia et al., 2015).”
BackgroundInfluentialGeetha, N. S., Bobby, Z., Dorairajan, G., & Jacob, S. E. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1730322 · Cited by 46
“Scindia et al have shown in their animal study that treatment with hepcidin reduced ischemia reperfusion injury and oxidative stress [22].”
BackgroundNew insights into the role of heme oxygenase-1 in acute kidney injury
Nath, M. C., & Agarwal, A. (2020) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.20.091 · Cited by 42
“That hepcidin mice exhibited increased sensitivity to IRI, which is lessened by hepcidin protein administration, is evidence of the nephroprotective effects of hepcidin [57].”
BackgroundInfluentialCharlton, J., Xu, Y.-Z., Wu, T., Deronde, K., Hughes, J. L., Dutta, S., Oxley, G. T., Ćwiȩk, A., Cathro, H., Charlton, N., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.08.021 · Cited by 37
Heme Proteins and Kidney Injury: Beyond Rhabdomyolysis
Nath, K. A., Singh, R. D., Croatt, A. J., & Adams, C. M. (2022) · Kidney360 · doi:10.34067/kid.0005442022 · Cited by 54
“Hepcidin, a protein involved in iron homeostasis and one that may suppress inflammation, is protective in IRI (98), and, interestingly, hepcidin protects cells of the distal nephron against cell death caused by Hb/heme (99).”
BackgroundInfluentialZhang, C.-H., Yan, Y.-J., & Luo, Q. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122439 · Cited by 41
Remote organ failure in acute kidney injury.
Kao, C., Yang, W.-S., Fang, J.-T., Liu, K. D., & Wu, V.-C. (2019) · Journal of the Formosan Medical Association = Taiwan yi zhi · doi:10.1016/j.jfma.2018.04.005 · Cited by 33
Proximal Tubule CD73 Is Critical in Renal Ischemia-Reperfusion Injury Protection
Sung, S. J., Li, L., Huang, L., Lawler, J. R., Ye, H., Rosin, D. L., Vincent, I. S., Le, T. H., Yu, J., Görldt, N., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016020229 · Cited by 36
Self-citationChen, S.-Y., Chen, T.-T., Xu, C., Yu, X.-H., Shi, J.-Y., Yang, C., & Zhu, T.-Y. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103795 · Cited by 30
“Yogesh Scindia et. raised iron overload post RIRI and some studies have re-ported disruption of metal ion homeostasis plays a crucial role in the development of RIRI [28].”
Xie, X., Zhang, Y., Su, X., Wang, J., Yao, X., Lv, D., Zhou, Q., Mao, J., Chen, J., Han, F., et al. (2022) · Nano Research · doi:10.1007/s12274-022-4257-y · Cited by 33
Ferritin in Kidney and Vascular Related Diseases: Novel Roles for an Old Player
Balla, J., Balla, G., & Zarjou, A. (2019) · Pharmaceuticals · doi:10.3390/ph12020096 · Cited by 32
“Another line of evidence to support the role of FtH in protecting the kidney against injurious insults comes from a more recent study by Scindia and colleagues [77].”
BackgroundResultInfluentialZager, R. A., Johnson, A. C. M., & Frostad, K. B. (2016) · Kidney International · doi:10.1016/j.kint.2016.01.022 · Cited by 35
Zhu, Y., Yin, X., Li, J., & Zhang, L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.04.023 · Cited by 27
Xu, G., Zhang, J., Shao, C., Wu, H., Shen, J., Wang, Y., Li, Y., Li, C., Yu, L., Zhou, H., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.013 · Cited by 28
Attenuation of Sepsis-Induced Acute Kidney Injury by Exogenous H2S via Inhibition of Ferroptosis
Zhang, L., Rao, J., Liu, X., Wang, X., Wang, C., Fu, S., & Xiao, J. (2023) · Molecules · doi:10.3390/molecules28124770 · Cited by 25
“, who reported that AKI induced by IRI caused ferroptosis in kidney cells [31].”
BackgroundZhang, L., Fu, X., Gui, T., Wang, T., Wang, Z., Kullak-Ublick, G. A., & Gai, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246280 · Cited by 27
“The other oxidative stress-producer is the inflammatory cell such as monocytes and macrophages, which infiltrate into tissue, especially during acute inflammation [27].”
BackgroundIron as an emerging therapeutic target in critically ill patients
Grange, C., Lux, F., Brichart, T., David, L., Couturier, A., Leaf, D. E., Allaouchiche, B., & Tillement, O. (2023) · Critical Care · doi:10.1186/s13054-023-04759-1 · Cited by 30
“The use of exogenous hepcidin could restore iron homeostasis by increasing ferritin expression and iron sequestration, leading to renal protection and a reduction in renal oxidative stress and inflammation in animal models of AKI [106, 107].”
BackgroundConstruction and Validation of a Ferroptosis-Related Prognostic Model for Endometrial Cancer
Wang, H., Wu, Y., Chen, S., Hou, M., Yang, Y., & Xie, M. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.729046 · Cited by 22
Iron deficiency after kidney transplantation
Vinke, J. S. J., Francke, M. I., Eisenga, M. F., Hesselink, D. A., & de Borst, M. H. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa123 · Cited by 31
“In a mouse model, renal IRI results in an iron shift from the liver and macrophages towards the kidneys and circulation, through the induction of the iron exporter ferroportin [105].”
BackgroundTherapeutic Opportunities for Hepcidin in Acute Care Medicine
Chawla, L. S., Beers-Mulroy, B., & Tidmarsh, G. F. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2018.11.014 · Cited by 28
van Swelm, R. P. L., Vos, M., Verhoeven, F., Thévenod, F., & Swinkels, D. W. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0568-z · Cited by 25
Tang, Q., Li, J., Wang, Y., & Sun, Q. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110393 · Cited by 22
Ischia, J. J., Bolton, D. M., & Patel, O. (2019) · Metallomics · doi:10.1039/c9mt00079h · Cited by 20
Elevated serum iron level is a predictor of prognosis in ICU patients with acute kidney injury
Shu, J., Hu, Y.-F., Yu, X.-S., Chen, J., Xu, W.-W., & Pan, J.-Y. (2020) · BMC Nephrology · doi:10.1186/s12882-020-01965-9 · Cited by 19
Lou, X.-F., Lu, J., Wang, C., Song, Y., Zhu, L., You, Y., Zhang, J., Hu, J., Xu, X., Xu, X., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143227 · Cited by 20
Arctigenin: A two-edged sword in ischemia/reperfusion induced acute kidney injury.
Han, F., Xia, X.-X., Dou, M., Wang, Y.-X., Xue, W., Ding, X., Zheng, J., Ding, C., & Tian, P. (2018) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2018.04.169 · Cited by 18
Urinary Hepcidin-25 Is Elevated in Patients That Avoid Acute Kidney Injury Following Cardiac Surgery
Choi, N., Rigatto, C., Zappitelli, M., Gao, A., Christie, S., Hiebert, B. M., Arora, R. C., & Ho, J. (2018) · Canadian Journal of Kidney Health and Disease · doi:10.1177/2054358117744224 · Cited by 20
“Urinary hepcidin-25 was identified as a novel biomarker of acute kidney injury (AKI) using proteomic techniques21, and its diagnostic performance has been evaluated in adult cardiac surgery cohorts.22,37,38 Recently, exogenously administered hepcidin-25 has been shown to be renoprotective in murine models of renal isc…”
BackgroundResultInfluentialRagy, M. M., & Aziz, N. M. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0197 · Cited by 13
Ferritinophagy and organ injury
Shao, N., Yu, H., Li, X., Han, M., Chen, C., Zhu, J., Tang, Y., Dong, J., & Chen, H. (2026) · Autophagy · doi:10.1080/15548627.2026.2633246 · Cited by 27
“Restoration of systemic and cellular iron homeostasis through modulation of HAMP/hepcidin and SLC40A1/ferroportin further strengthens this strategy [143,144].”
Change in iron metabolism in rats after renal ischemia/reperfusion injury
Xie, G.-L., Zhu, L., Zhang, Y., Zhang, Q.-N., & Yu, Q. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175945 · Cited by 16
Salama, R. M., Darwish, S. F., Yehia, R., Sallam, A. A., Elmongy, N. F., Abdel-Galil, M., & Wakeel, S. A. E. (2024) · Food and Chemical Toxicology · doi:10.1016/j.fct.2024.115027 · Cited by 19
Zhao, Y., Jiang, B., Huang, D., Lou, J., Li, G., Liu, J., Duan, F., Yuan, Y., & Su, X. (2023) · PeerJ · doi:10.7717/peerj.15786 · Cited by 17
“Furthermore, studies have elucidated the relationship between AKI and iron metabolism ( Scindia et al., 2015 ), while others have proposed that iron-mediated cell death may be the principal driving factor in various ischemic injury models ( Tonnus & Linkermann, 2017 ).”
Iron metabolism and chronic inflammation in IgA nephropathy
Tian, Z.-Y., Li, Z., Chu, L., Liu, Y., He, J., Yu, X., Li, A., & Zhang, H. (2023) · Renal Failure · doi:10.1080/0886022x.2023.2195012 · Cited by 26
Distinctive modulation of hepcidin in cancer and its therapeutic relevance
Lin, F., Tuffour, A., Hao, G., Addai, F. P., Huang, A., Zhou, Y., & Zhang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1141603 · Cited by 20
“IL-6 and interferon-alpha may cause interstitial renal leukocytes to increase the expression of hepcidin, with interferon-alpha having a more substantial effect on renal monocytes than hepatocytes (106).”
BackgroundKarkouti, K., Yip, P. S. F., Chan, C. T., Chawla, L. S., & Rao, V. A. (2018) · Anaesthesia · doi:10.1111/anae.14274 · Cited by 20
“In a mouse model, exogenous hepcidin administration limited kidney injury associated with hepcidin deficiency [27].”
BackgroundProtective Effect of Thioctic Acid on Renal Ischemia–reperfusion Injury in Rat
Ahmadvand, H., & Mahdavifard, S. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_396_17 · Cited by 14
“Therefore, TA is a perfect treatment for prevention of IRI.”
InfluentialTurning over renal osteodystrophy dogma: direct actions of FGF23 on osteoblast β-catenin pathway
Schiavi, S. C., & Moysés, R. M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.028 · Cited by 12
Jia, D.-G., Wu, K., Luo, J., Xu, X.-S., Pan, W., Zhao, M.-J., Li, S.-W., Gong, J.-P., & Gong, J.-H. (2024) · Transplantation · doi:10.1097/tp.0000000000005123 · Cited by 11
Diepeveen, L. E., Stegemann, G., Wiegerinck, E. T. G., Roelofs, R., Naber, M. R., Loréal, O., Smeets, B., Thévenod, F., Swinkels, D. W., & van Swelm, R. P. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031352 · Cited by 13
“In vivo studies strengthened the idea of hepcidin exerting a renoprotective effect, since renal damage was shown to be reduced upon intraperitoneal administration of hepcidin during both ischemia–reperfusion injury and hemoglobin-induced injury [15,17].”
BackgroundThe Yin and Yang of Alarmins in Regulation of Acute Kidney Injury
Sabapathy, V., Venkatadri, R., Doğan, M., & Sharma, R. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00441 · Cited by 11
“Administration of the iron-regulating hormone hepcidin reduced inflammation and decreased oxidative stress inmousemodels of AKI (181).”
BackgroundShen, Z.-Y., Lin, J., Teng, J., Zhuang, Y.-M., Zhang, H. J., Wang, C.-S., Zhang, Y., Ding, X., & Zhang, X.-Y. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.02.095 · Cited by 11
Yan, D., Wu, Z., & Qi, X. (2023) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2023.02.008 · Cited by 9
Heme Burden and Ensuing Mechanisms That Protect the Kidney: Insights from Bench and Bedside
Balla, J., & Zarjou, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158174 · Cited by 12
“Through subsequent studies, Scindia and colleagues recapitulated the protective effects of hepcidin in AKI and postulated that hepcidin exerts such effects through increased iron retention with subsequent upregulation of intracellular ferritin [137].”
BackgroundProbst, S., Fels, J., Scharner, B., Wolff, N. A., Roussa, E., van Swelm, R. P. L., Lee, W., & Thévenod, F. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03106-z · Cited by 9
Hepcidin protects pulmonary artery hypertension in rats by activating NF-κB/TNF-α pathway.
Liu, W.-Y., Wang, L., & Lai, Y. (2019) · European Review for Medical and Pharmacological Sciences · doi:10.26355/eurrev_201909_18878 · Cited by 10
The role of ferroptosis in acute kidney injury: mechanisms and potential therapeutic targets
Yu, Y., Zhang, L., Zhang, D., Dai, Q., Hou, M., Chen, M., Gao, F., & Liu, X. (2024) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-024-05056-3 · Cited by 14
“Hepcidin plays a crucial role in protecting cells from ferroptosis by inhibit‑ ing the expression of ferroportin and the export of cellu‑ lar iron, while also upregulating ferritin [271].”
Ou, Y., Li, J.-R., Wu, C.-C., Yu, T.-M., Chen, W.-Y., Liao, S.-L., Kuan, Y.-H., Chen, Y.-F., & Chen, C.-J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112846 · Cited by 9
Zager, R. A., Johnson, A. C. M., & Therapeutics, R. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa348 · Cited by 10
Diagnostic ability of hepcidin in predicting fetal outcome in preeclampsia
Nila, S. G., Bobby, Z., Dorairajan, G., & Jacob, S. E. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1689561 · Cited by 11
Navarrete, M., Ho, J., Dwivedi, R. C., Choi, N., Ezzati, P., Spicer, V., Arora, R. C., Rigatto, C., & Wilkins, J. A. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00500 · Cited by 8
Acute Kidney Injury Prevention
Chopra, T., Brooks, C. H., & Okusa, M. D. (2016) · Contributions to nephrology · doi:10.1159/000443152 · Cited by 9
Self-citationZhang, Y., Xing, J., Yao, L., Zou, Y. F., Peng, H., Yi, X., Bai, L., Yu, Y., Liu, H., Li, X., et al. (2025) · Antioxidants and Redox Signaling · doi:10.1177/15230864251369883 · Cited by 7
“In addition, hepcidin downregulates FPN expression, and treatment with exogenous hepcidin has been shown to mitigate the iron homeostatic disruptions induced by renal IRI (Scindia et al., 2015).”
Qian, Z., Zhang, X., Huang, J., Hou, Y., Hu, C., Cao, Y., Wu, N., Zhu, T., & Wu, G. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.05.390 · Cited by 9
Qi, Y., Hu, M., Wang, Z., & Shang, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115725 · Cited by 7
Metadata
- Authors
- Scindia, Y., Dey, P., Thirunagari, A., Liping, H., Rosin, D. L., Floris, M., Okusa, M. D., & Swaminathan, S.
- Affiliations
- University of Virginia Health System (US)
- Azienda Ospedaliera G. Brotzu (IT)
- Corresponding author
- Scindia, Yogesh
- Dey, Paromita
- Thirunagari, Abhinav
- Liping, Huang
- Floris, Matteo
- Okusa, Mark D.
- Swaminathan, Sundararaman
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-11
- Volume
- 26
- Issue
- 11
- Pages
- 2800-2814
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4625680
- OpenAlex
- W2010431026
- Cited by
- 141
- References
- 0
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 13 · 2023: 17 · 2022: 15 · 2021: 12 · 2020: 17 · 2019: 18 · 2018: 15 · 2017: 6 · 2016: 9 · 2015: 3
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
- Funders
- University of Virginia
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hepcidin, renal ischemia-reperfusion injury, acute kidney injury, ferroportin, H-ferritin, oxidative stress, renal inflammation, interleukin-6, renal tubular injury, apoptosis
- MeSH terms
- Animals, Gene Expression Regulation, Homeostasis, Inflammation, Iron, Kidney, Male, Mice, Inbred C57BL, Mice, Transgenic, Microscopy, Fluorescence, Spleen, Reperfusion Injury, Interleukin-6, Apoptosis, Leukocyte Common Antigens, Oxidative Stress, In Situ Nick-End Labeling, Mice, Acute Kidney Injury, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.